Global Next Generation Sequencing (NGS) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Next Generation Sequencing (NGS) estimated at US$ 5572.9 million in the year 2022, is projected to reach a revised size of US$ 8843.5 million by 2028, growing at a CAGR of 8.0% during the forecast period 2022-2028.

The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future.

Report Scope

This latest report researches the industry structure, revenue and gross margin.

Major players

’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Next Generation Sequencing (NGS) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Next Generation Sequencing (NGS) market. Further, it explains the major drivers and regional dynamics of the global Next Generation Sequencing (NGS) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Illumina

Thermo Fisher Scientific

Pacific Biosciences of California

Beijing Genomics Institute

Qiagen

Roche

Agilent Technologies

Perkinelmer

Genomatix

PierianDx

Eurofins Scientific

Gatc Biotech

Oxford Nanopore Technologies

Bio-Rad Laboratories

DNASTAR

Biomatters

Partek

New England Biolabs

Myriad Genetics

Macrogen

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Next Generation Sequencing (NGS)
Segment by Type


Targeted Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

Next Generation Sequencing (NGS)
Segment by Application


Academic & Government Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Hospitals & Clinics

Key Regions

& Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA


Key Drivers & Barriers



High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.


COVID-19 and Russia-Ukraine War Influence Analysis


The readers in the section will understand how the Next Generation Sequencing (NGS) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Next Generation Sequencing (NGS) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Next Generation Sequencing (NGS), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next Generation Sequencing (NGS), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next Generation Sequencing (NGS) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Next Generation Sequencing (NGS) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Next Generation Sequencing (NGS) revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Illumina, Thermo Fisher Scientific, Pacific Biosciences of California, Beijing Genomics Institute, Qiagen, Roche, Agilent Technologies, Perkinelmer and Genomatix, etc.